The Role of Macrolide Antibiotics in Increasing Cardiovascular Risk
- 1 November 2015
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 66 (20), 2173-2184
- https://doi.org/10.1016/j.jacc.2015.09.029
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Current and Former Smoking and Risk for Venous Thromboembolism: A Systematic Review and Meta-AnalysisPLoS Medicine, 2013
- Towards Universal Voluntary HIV Testing and Counselling: A Systematic Review and Meta-Analysis of Community-Based ApproachesPLoS Medicine, 2013
- Early Repolarization Pattern and Risk for Arrhythmia Death: A Meta-AnalysisJournal of the American College of Cardiology, 2013
- Azithromycin and the Risk of Cardiovascular DeathNew England Journal of Medicine, 2012
- Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trialsBMJ, 2011
- Azithromycin distinctively modulates classical activation of human monocytes in vitroBritish Journal of Pharmacology, 2011
- Exercise-Induced Repolarization Changes in Patients With Stable Coronary Artery DiseaseThe American Journal of Cardiology, 2011
- Drug-Induced Long QT SyndromePharmacological Reviews, 2010
- Drug‐induced torsades de pointes: data mining of the public version of the FDA Adverse Event Reporting System (AERS)Pharmacoepidemiology and Drug Safety, 2009
- Azithromycin‐Induced Torsade De PointesPacing and Clinical Electrophysiology, 2007